The distribution of pro- or anti-inflammatory markers in MS tissue reveals the predominance of myeloid cells with an intermediate activation status, as defined by the coexpression of CD40 (typical of pro-inflammatory APCs) and the mannose receptor (CD206, typical of anti-inflammatory macrophages) at active lesions [133]. This evidence concerns the gene CD40 and myeloid sarcoma.